Ocular Adverse Effects of Gefitinib: A Case Report

Gefitinib is a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. It is used for treating locally advanced or metastatic non-small cell lung carcinoma and is well tolerated systemically. However, sight-threatening ocular adverse effects, like corneal ulcer and perforation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeria, Sandhya, Thool, Archana R, Daigavane, Sachin, Ganjre, Samyak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599912/
https://www.ncbi.nlm.nih.gov/pubmed/36320985
http://dx.doi.org/10.7759/cureus.29600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599912/
https://www.ncbi.nlm.nih.gov/pubmed/36320985
http://dx.doi.org/10.7759/cureus.29600

Ejemplares similares